01.09.2014
- German neurologists are standing by currently prescribed interferon-based multiple sclerosis treatments, despite a warning issued by the Federal Institute for Drugs and Medical...
06.02.2013
- Biogen is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.25 billion plus future royalties on sales of the drug...
01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
02.05.2012
- Biogen's quarterly profit fell short of analysts' estimates on weak sales of its Avonex multiple sclerosis treatment, its biggest-selling product. But the biotechnology company...
20.04.2012
- European regulators have endorsed the continued use of Novartis's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said on Friday the drug needed to...
